Annette Rid
#138,697
Most Influential Person Now
Bioethicist and physician-scientist
Annette Rid's AcademicInfluence.com Rankings
Annette Ridphilosophy Degrees
Philosophy
#8892
World Rank
#12356
Historical Rank
Applied Ethics
#18
World Rank
#18
Historical Rank
Bioethics
#78
World Rank
#78
Historical Rank
Logic
#8816
World Rank
#11082
Historical Rank
Download Badge
Philosophy
Annette Rid's Degrees
- Doctorate Medicine Stanford University
- PhD Bioethics Stanford University
Why Is Annette Rid Influential?
(Suggest an Edit or Addition)According to Wikipedia, Annette Rid is a bioethicist and physician-scientist specialized in research ethics, global health ethics, and justice in health and health care. She works at the National Institutes of Health Clinical Center.
Annette Rid's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Systematic Review: The Effect on Surrogates of Making Treatment Decisions for Others (2011) (544)
- meeting health needs fairly Just health: minisymposium on Norman Daniels' Justice in action? Introduction to the (2008) (120)
- Ethical considerations of experimental interventions in the Ebola outbreak (2014) (117)
- A Framework for Risk-Benefit Evaluations in Biomedical Research (2011) (109)
- Evaluating the risks of clinical research. (2010) (105)
- Ethics of controlled human infection to address COVID-19 (2020) (78)
- Disclosure of Incidental Findings From Next-Generation Sequencing in Pediatric Genomic Research (2013) (76)
- Research led by participants: a new social contract for a new kind of research (2015) (73)
- Justice and procedure: how does “accountability for reasonableness” result in fair limit-setting decisions? (2008) (70)
- Systematic Review: Individuals' Goals for Surrogate Decision‐Making (2012) (70)
- Universal health coverage, priority setting, and the human right to health (2017) (59)
- Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies (2015) (57)
- Standards of practice in empirical bioethics research: towards a consensus (2018) (56)
- Placebo use in vaccine trials: Recommendations of a WHO expert panel (2014) (45)
- Controversies in the determination of death: perspectives from Switzerland. (2012) (43)
- Use of a patient preference predictor to help make medical decisions for incapacitated patients. (2014) (42)
- Risks of phase I research with healthy participants: A systematic review (2016) (40)
- In Defense of a Social Value Requirement for Clinical Research (2017) (37)
- Risk-benefit assessment in medical research—critical review and open questions (2010) (34)
- Is the concept of clinical equipoise still relevant to research? (2017) (34)
- Ethical Rationale for the Ebola "Ring Vaccination" Trial Design. (2016) (31)
- Choices in vaccine trial design in epidemics of emerging infections (2018) (31)
- The 2008 Declaration of Helsinki — First among Equals in Research Ethics? (2010) (30)
- Cost effective but unaffordable: an emerging challenge for health systems (2017) (29)
- Why should high-income countries help combat Ebola? (2014) (29)
- Can We Improve Treatment Decision-Making for Incapacitated Patients? (2010) (29)
- The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials. (2020) (28)
- Setting risk thresholds in biomedical research: lessons from the debate about minimal risk (2014) (24)
- Innovation as a value in healthcare priority-setting: the UK experience (2019) (24)
- Treatment decision making for incapacitated patients: is development and use of a patient preference predictor feasible? (2014) (23)
- Phase I Cancer Trials and Palliative Care: Antagonism, Irrelevance, or Synergy? (2016) (23)
- Would you sell a kidney in a regulated kidney market? Results of an exploratory study (2009) (22)
- Public Reasoning and Health-Care Priority Setting: The Case of NICE (2017) (22)
- Tissue and Cell Donation: An Essential Guide (2009) (19)
- Patients' priorities for treatment decision making during periods of incapacity: quantitative survey (2014) (19)
- Just health: meeting health needs fairly (2008) (18)
- So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development (2020) (18)
- Public participation in decision-making on the coverage of new antivirals for hepatitis C. (2016) (18)
- A new method for making treatment decisions for incapacitated patients: what do patients think about the use of a patient preference predictor? (2016) (18)
- National Institute for Health and Care Excellence, social values and healthcare priority setting (2019) (17)
- The potential exploitation of research participants in high income countries who lack access to health care. (2016) (16)
- Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion. (2020) (15)
- Handbook of Risk Theory: Epistemology, Decision Theory, Ethics and Social Implications of Risk (2012) (15)
- What is Enough? Sufficiency, Justice, and Health (2016) (14)
- Prisoners as research participants: current practice and attitudes in the UK (2014) (14)
- Can informed consent to research be adapted to risk? (2014) (14)
- How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives. (2014) (14)
- When is Research Socially Valuable? Lessons From the Bucharest Early Intervention Project: Commentary on a Case Study in the Ethics of Mental Health Research (2012) (12)
- Tackling anti-microbial resistance: ethical framework for rational antibiotic use (2018) (12)
- A proposal and prototype for a Research Risk Repository to improve the protection of research participants (2011) (10)
- The effect on surrogates of making treatment decisions for others (2011) (10)
- Do patients want their families or their doctors to make treatment decisions in the event of incapacity, and why? (2016) (10)
- Challenges for the new Cancer Drugs Fund. (2016) (9)
- Substantiating the Social Value Requirement for Research: An Introduction. (2017) (8)
- The importance of being NICE (2015) (8)
- Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project (2021) (8)
- Towards Equity in Health: Researchers Take Stock (2016) (8)
- Genetic research on biospecimens poses minimal risk. (2015) (7)
- Advantages of Using Lotteries to Select Participants for High‐Demand Covid‐19 Treatment Trials (2020) (7)
- Evaluating the Risks of Public Health Programs: Rational Antibiotic Use and Antimicrobial Resistance (2019) (7)
- Ethical challenges for a new generation of early-phase pediatric gene therapy trials (2021) (6)
- Justice in action? Introduction to the minisymposium on Norman Daniels’ Just health: meeting health needs fairly (2008) (6)
- Evaluating the risks of clinical research: direct comparative analysis. (2014) (5)
- The Goals of Research During an Epidemic (2015) (5)
- Covid-19: Eine Ad hoc Public-Health-Ethikberatung (2020) (4)
- Regulating international clinical research: an ethical framework for policy-makers (2020) (4)
- [The newly revised Declaration of Helsinki: what do the changes mean from an ethical perspective?]. (2009) (4)
- Risk and risk-benefit evaluations in biomedical research (2012) (4)
- Public Health Ethics and Covid-19: The ethical dimensions of public health decision-making during a pandemic (2020) (3)
- Judging the Social Value of Controlled Human Infection Studies (2020) (3)
- Compassionate use of experimental drugs in the Ebola outbreak – Authors' reply (2014) (3)
- Placebo-Controlled Trials, Ethics of (2015) (3)
- [Covid-19: An ad hoc public health ethics consultation]. (2020) (2)
- Judging the Social Value of Health-Related Research: Current Debate and Open Questions (2020) (2)
- Individual and public interests in clinical research during epidemics: a reply to Calain (2017) (2)
- The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19. (2021) (2)
- Addressing exploitation of poor clinical trial participants in North America and the European Union. (2016) (2)
- Determination of Death: A Discussion on Responsible Scholarship, Clinical Practices, and Public Engagement (2015) (2)
- How Did Médecins Sans Frontières Negotiate Clinical Trials of Unproven Treatments During the 2014–2015 Ebola Epidemic? (2017) (2)
- Ethics of controlled human infection studies: Past, present and future. (2020) (2)
- Unnecessary hesitancy on human vaccine tests—Response (2020) (2)
- Will a patient preference predictor improve treatment decision making for incapacitated patients? (2014) (2)
- The Challenge of Selecting Participants Fairly in High-Demand Clinical Trials (2020) (2)
- The ethics of international research: The Constant Gardener (2011) (2)
- Affordability and Non-Perfectionism in Moral Action (2019) (2)
- Rethinking Risk–Benefit Evaluations in Biomedical Research (2016) (2)
- Die erneut überarbeitete Deklaration von Helsinki (2009) (2)
- Patients’ Priorities for Surrogate Decision-Making: Possible Influence of Misinformed Beliefs (2021) (1)
- Sufficiency, Health, and Health Care Justice (2016) (1)
- Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next steps. (2020) (1)
- The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O) (2021) (1)
- The newly revised declaration of Helsinki (2009) (1)
- Informed Consent for Controlled Human Infection Studies in Low‐ and Middle‐Income Countries: Ethical Challenges and Proposed Solutions (2020) (1)
- Faire Allokationsprozesse: zum Verhältnis von substantieller und prozeduraler Gerechtigkeit in Norman Daniels’ Just Health (2010) (1)
- A Rid decisions ? for reasonableness " result in fair limit-setting Justice and procedure : how does " accountability (2008) (0)
- 140:poster The ethics of global COVID-19 vaccine allocation (2022) (0)
- Ethical Considerations in the Second Decade of Pediatric Phase I CAR T-Cell Trials (2023) (0)
- Short literature notice: Steinbock, B. (ed.): 2007, The Oxford Handbook of Bioethics. New York: Oxford University Press. 747 pages. ISBN 978-0-19-927335-5. Price: £ 85. (2008) (0)
- Gibt es eine universale Bioethik (2008) (0)
- Year : 2009 Would you sell a kidney in a regulated kidney market ? Results of an exploratory study Rid ( (2010) (0)
- Title Towards equity in health : researchers take stock (2016) (0)
- Books and electronic media Just health : meeting health needs fairly (0)
- Tackling Anti-microbial Resistance: An Ethical Framework for Rational Antibiotic Use (2020) (0)
- Note of clarification concerning our article: controversies in the determination of death: perspectives from Switzerland. (2013) (0)
- The Next Wave in Health Care Priority Setting. (2018) (0)
- The Cambridge Textbook of Bioethics (2008) (0)
- Kommentar I zum Fall: „Heimlicher Transfer von HIV-Medikamenten nach Afrika“ (2012) (0)
- Joachim Boos, Reinhard Merkel, Heiner Raspe, Bettina Schöne-Seifert (Hrsg) (2009) Nutzen und Schaden aus klinischer Forschung am Menschen. Abwägung, Equipoise und normative Grundlagen (2010) (0)
- The ethics of placebo-controlled trials (2015) (0)
- Ethical trade-offs in vaccine development and distribution—Response to Gurwitz (2021) (0)
- Innovation as a value in healthcare priority-setting: the UK experience (2019) (0)
- Note of Clarification (1992) (0)
- Ethik an der Weltgesundheitsorganisation (2010) (0)
- Faire Entscheidungsprozesse und Gerechtigkeit in der Gesundheitsversorgung: das Beispiel von Norman Daniels Accountability for Resonableness (2012) (0)
- Ethics and Governance in Biomedical Research. Concepts, Methods, Case Studies (2014) (0)
- Book review: Loretta M. Kopelman: 2006, Research with children. Access vs. protection, Oxford, New York: Oxford University Press (2006) (0)
- Standards of practice in empirical bioethics research: towards a consensus (2018) (0)
- Book review: Peter A. Singer/Adrian M. Viens (Eds.): 2008, The Cambridge Textbook of Bioethics, Cambridge: Cambridge University Press (2008) (0)
- Setting risk thresholds in biomedical research: lessons from the debate about minimal risk (2014) (0)
This paper list is powered by the following services:
Other Resources About Annette Rid
What Schools Are Affiliated With Annette Rid?
Annette Rid is affiliated with the following schools:
